EisaiEisai Glossary Eisai Glossary

 ANDA
 Pharmaceuticals/treatments 
U.S. acronym for Abbreviated New Drug Application (a simplified application procedure for approval of derivative drugs). In the U.S., there is a simplified procedure to be followed by manufacturers of derivatives (generic manufacturers) when applying for approval of new products derived from and having the same efficacy as previously released pharmaceuticals. If the derivative manufacturer can show that when the new drug is taken it is distributed by the blood in the same manner as its predecessor, it can then utilize the clinical research data on the safety and efficacy of the drug's predecessor in the application for approval. This will enable derivative manufacturers to reduce R&D costs and provide products at a lower price.

close


Copyright (C) Eisai Co., Ltd. All Rights Reserved.